IL15 and neoplasm: In our study, we found that IL-15 combined with IL-15Ra reduced adverse events significantly during CAR-T therapy that had the potential ability to prolong the survival rate of tumor-treated mice with the health liver and lower GVHD score, indicating a novel function of IL-15Ra.